Persephone, Kroger Health partner to unveil AMBROSIA Food as Medicine study
The study is intended to assess the effect of diet quality, food characteristics and lifestyle factors on participants’…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
20 Oct 23
The study is intended to assess the effect of diet quality, food characteristics and lifestyle factors on participants’…
20 Oct 23
The Phase I trial is designed as a multi-center, randomized, double-blind, placebo-controlled study to investigate the safety, tolerability,…
18 Oct 23
Takeda said the safety profile of Alofisel remained in line with previous research, with no new safety concerns…
16 Oct 23
Skyrizi is an interleukin-23 inhibitor that selectively blocks IL-23, a cytokine involved in inflammatory processes and is associated…
16 Oct 23
The designation was given based on positive data from the Phase 1 part of the ongoing Phase 1/2…
16 Oct 23
With no dose-limiting toxicities observed, treatment of second dose cohort to begin
16 Oct 23
The Company will host an investor event following the presentation after the close of market on Thursday, November 2nd
13 Oct 23
In the mirikizumab arm of the study, 45.4% of patients achieved clinical response at week 12 and clinical…
13 Oct 23
In the trial, Rinvoq showed a percent change from baseline in the Facial Vitiligo Area Scoring Index at…
10 Oct 23
In the trial, patients treated with Vabysmo extended their treatment intervals up to every four months while maintaining…